ArticleDrug delivery and translational research2022
Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model.
Lok R Pokhrel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it